Logo Home   Create   Site Settings   Help    Up to North West Public Health
Publications and Outputs
Folder

 
 
 
Icon Home
Icon Cancer Registration Background
Icon NWCIS
Icon Cancer Information in the North West
Icon Teenagers and Young Adults (TYA)
Icon Contacts and Links
Icon Publications
Icon Annual Report
Icon Team Briefs
Icon
 
 
Icon

Publications and Outputs

Upload Upload Document
|
New Folder New Folder
|
Filter Filter
|  
TypeNameDocument TitleAuthorsDate Published
Icon
Lung Cancer in the North West
Lung cancer in the North WestMöller H, Shack L and Moran A
26/09/2008
Icon
Excess cancer mortality and incidence by PCT in the North West, 2001-2005
Excess cancer mortality and incidence by PCT in the North West, 2001-2005Lemon D, Flatt G, Shack L, Ellison T, Moran T
17/12/2007
Icon
Table of observed, expected and excess cancer incidence and deaths, NW, 2001-2005
Table of observed, expected and excess cancer incidence and deaths (numbers and percentages) for the North West PCTs, 2001-2005Lemon D, Flatt G, Shack L, Ellison T, Moran T
16/12/2007
Icon
Cancer Incidence Projections North West
Cancer Incidence Projections North WestShack L, Khan S, Moran T
04/07/2007
Icon
Cancer in the North West- Trends and Comparisons
Cancer in the North West- Trends and ComparisonsMoran T, Chandler D, Iddenden R
05/04/2007
Icon
Spearhead Primary Care Trusts and progress towards decreasing cancer mortality, North West, 1995-2005
Spearhead Primary Care Trusts and progress towards decreasing cancer mortality, North West, 1995-2005.Flatt G, Shack L, Moran T
02/04/2007
Icon
CM Lung cancer report
Lung Cancer in Cheshire and MerseysideMöller H, Shack L, Ashraf A
01/10/2006
Icon
Cancer Incidence and Mortality in North West Cancer Networks 1996-2001

 

Publications (full authorship)

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women greater than or equal to 65 years

K Lavelle, C Todd, A Moran, A Howell, N Bundred, M Campbell

British Journal of Cancer 96, 1197 - 1203 (23 Apr 2007)

Women with Neurofibromatosis 1 (NF1) are at a moderately increased risk of developing breast cancer and should be considered for early screening
Saba Sharif, Anthony Moran, Susan Huson, Richard Iddenden, Andrew Shenton, Elizabeth Howard and Gareth Evans

published online 16 Mar 2007; J. Med. Genet. AWAITING PUBLICATION

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

A Smith, A Moran, M C Boyd, M Bulman, A Shenton, L Smith, R Iddenden, E R Woodward, F Lalloo, E R Maher, D G R Evans

J. Med. Genet., Jan 2007; 44: 10 - 15
Malignant peripheral nerve Sheath Tumours in Neurofibromatosis 1
Evans DGR, Shariff S, Howard E, McGaughran J, Baser M, Moran A.
Journal of Medical Genetics 2002;39:311-314
Histopathological types of benign breast lesions and the risk of breast cancer: case-control study.
A.M. Shaaban, J.P. Sloane, C.R. West, F.R. Moore, C. Jarvis, E.M.I. Williams, C.S. Foster. Am J Surg Pathol. 2002 Apr; 26(4):421-30
Prediction of pathogenic mutations in patients with early onset breast cancer
Lalloo F, Varley J, Ellis D, Moran A, O’Dair L, Pharoah P, Evans DGR and The Early Onset Breast Cancer Study Group.
Lancet 2003; 361:1101-1102
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. 
Amir E, Evans DGR, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A.
Journal of Medical Genetics 2003;40:807-814
Genetic analysis of mitochondrial complet II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. 
Astuli D, Hart-Holden N, Latif F, Lalloo F, Black G, Lim C, Moran A, Grossman A, Hodgson S, Freemont A, Ramsden R, Eng C, Evans G, Maher E.
Clinical Endocrinology 2003;59:728-733
Socioeconomic variation in colon cancer tumour factors associated with poorer prognosis
G. Lyratzopoulos, C.R. West, E.M.I. Williams
Br. J. Cancer, 2003 Sep 1:89(5):828-30
The effects of an awareness-raising program for patients and primary care physicians on the early detection of gastro-oesophageal cancer
P. McCulloch, P. J. B. Brown, B. Martin, E.M.I. Williams
Surgery, 2003 Feb; 133(2):154-61
Bladder cancer: worse survival in women from deprived areas. 
Moran A, Sowerbutts AM, Collins S, Clarke N, Cowan R.
British Journal of Cancer 2004;90:2142-2144
Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North West of England over a 10-year Period: Higher Incidence than Previously Thought.
Evans DGR, Moran A, King A, Saeed S, Gurunsinghe N, Ramsden R. 
Oncology & Neurotology 2005;26:93-97
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Lalloo F, Varley J, Moran A, Ellis D, O’Dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DGR.   
EJC 2006;42:1143-1150
Papers (Membership of Working Groups)
Cancer Prevalence in European registry areas
A. Micheli, E. Mugno, V. Krogh, M.J. Quinn, M.  Coleman, T. Hakulinen, G. Gatta, F. Berrino, R. Capocaccia, EUROPREVAL Working Group.
Annals of Oncology 2002; 13:840-865, 2002
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
M. Sant, C. Allemani, R. Capocaccia, T. Hakulinen, T. Aareleid, J.W. Coebergh, M.P. Coleman, P. Groscalude, C. Martinez, J. Bell, J. Youngson, F. Berrino and the EUROCARE working group.
Int. J. Cancer: 106, 416-422 (2003)
Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case control study
A.J. Swerdlow, M.E.Jones and the British Tamoxifen Second Cancer Study Group
J Natl Cancer Inst 97: 375-384, 2005
Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case control study
A.J. Swerdlow, M.E.Jones and the British Tamoxifen Second Cancer Study Group
Presentations at national and international conferences
Do older women get poorer treatment after breast conserving surgery?
Moran A. Lavelle K, Bundred N 
Association of Surgeons of Great Britain and Ireland, Annual Scientific Meeting. May 22-24 2002 Dublin
Experience of Pancreatic euroendocrine Tumours at the Royal Liverpool University and Broadgreen Hospital Trust – A case series
H.E. Doran, F. Campbell, L. Bosonnet, C. Garvey, W. Fraser, M. Lombard, J. Vora, P. Ghaneh, M. Hartley, J.P. Neoptolemos, E.M.I. Williams, R. Sutton
North West Society of Surgeons Annual Meeting, October 2002
  
Why do women with bladder cancer have a worse prognosis than men?
Moran A. et al
British Association of Urological Surgeons, annual meeting, Manchester 23-27 June 2003
To what extent does non-standard management of breast cancer increase with advancing age
Moran A, Lavelle K, Bundred NJ 
8th Nottingham International Breast Cancer Conference, Nottingham 16-19 September 2003
A puff too far: An audit of smoking information routinely collected by Merseyside and Cheshire Cancer Registry, and its use in survival analyses
R. Iddenden, E.M.I. Williams, M. Murphy
12th Annual Conference of the UK Association of Cancer Registries,
Cardiff, October 2003
Is cancer control improving in the elderly?
Moran T, Lewis H, Iddenden R
14th Annual Conference of the UK Association of Cancer Registries,
Manchester, September 2005
The risk of breast cancer in women who test negative for the family BRCA mutation
Iddenden R, Moran T,Smith A, Evans G
14th Annual Conference of the UK Association of Cancer Registries,
Manchester, September 2005
Survival from cancer in teenagers and young adults in England: a national population-based study
Pang d, Alston R, Rowan S, Moran T, Kelsey A, Eden T, Birch J
15th Annual Conference of the UK Association of Cancer Registries,
Amsterdam, The Netherlands, October 2006
Posters
“Determining the epidemiology of pancreatic endocrine tumours using cancer registration data; a case where tumour histology is not enough”
H.E. Doran, R. Sutton, F. Campbell, E.M.I. Williams
International Association of Cancer Registries Annual Meeting 2002, Tampere, Finland, July 2002
“Exploring the difficulties experienced using cancer registry data for the epidemiological study of rare tumours: carcinoid as an example.”
H.E. Doran, R. Sutton, F. Campbell, E.M.I. Williams
International Association of Cancer Registries Annual Meeting 2002, Tampere, Finland, July 2002
“The Merseyside and Cheshire Cancer Registry (MCCR) and the Retained Organs Commission (ROC): A tale of needles in haystacks?
E.M.I. Williams, T. Clegg, K. Chester, R. Iddenden
11th Annual Conference of the UK Association of Cancer Registries, Leeds, September 2002
“Creation of a Data Dictionary”
S. Bishop, G. Hayton, I. Hodge, K. Chester, E.M.I. Williams
12th Annual Conference of the UK Association of Cancer Registries, Cardiff, October 2003
“Collaboration in the North West: A Tale of Two Cancer Registries”
R. Iddenden, J. Peers, C. Jones, D. Chandler, E.M.I. Williams
12th Annual Conference of the UK Association of Cancer Registries, Cardiff, October 2003
“Saving Lives: Our Healthier Nation” Mortality reduction targets at half-time:  Will Merseyside and Cheshire Primary Care Trusts score?
R. Iddenden, E.M.I. Williams
12th Annual Conference of the UK Association of Cancer Registries, Cardiff, October 2003
“Two hospitals, one NHS Trust and two Cancer Registries: checking ascertainment of cancer registrations”
R. Iddenden, G. Hayton, J. Septon, A. Watkinson, E.M.I. Williams
13th Annual Conference of the UK Association of Cancer Registries, London, September 2004
“Getting place of death via the NHS strategic tracing service (NSTS).  Computing a place of death and cancer network region code from electronic death certificates”
G. Hayton, R. Iddenden, K. Chester, G. Hamblin, E.M.I. Williams
13th Annual Conference of the UK Association of Cancer Registries, London, September 2004
“Patient by numbers: Making use of the NHS strategic tracing service (NSTS) batch process via e-mail”
G. Hayton, E.M.I. Williams
13th Annual Conference of the UK Association of Cancer Registries, London, September 2004
“Where are those children?”
K. Chester, L. Wilcox, R. Iddenden, E.M.I. Williams
13th Annual Conference of the UK Association of Cancer Registries, London, September 2004
“Increased risk of breast cancer after radiotherapy for Hodgkin’s disease – patient notification exercise”
Preston-Campion J, Kennedy, J, Hartley R, Moran T
13th Annual Conference of the UK Association of Cancer Registries, London, September 2004
“PRAXIS – the automated cancer registration system”
 Hartley R, Cooke D, PRAXIS Board Members, PRAXIS User Group Members, PRAXIS consortium
14th Annual Conference of the UK Association of Cancer Registries, Manchester, September 2005
“Where do Lung Patients die on Merseyside and Cheshire?”
J Kelly, H Moeller, L Shack, S Bishop, G Hayton, E.M.I. Williams
1) Palliative Care Conference, Liverpool, May 2005
2) 14th Annual Conference of the UK Association of Cancer Registries, Manchester, September 2005
“Who dies where in Merseyside and Cheshire?”
J Kelly, H Moeller, L Shack, S Bishop, G Hayton, E.M.I. Williams
14th Annual Conference of the UK Association of Cancer Registries, Manchester, September 2005